Neal Joshi
Overview
Explore the profile of Neal Joshi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Joshi N, Li J, Karambelkar A, Boere P
J Radiol Case Rep
. 2024 Jun;
18(1):14-19.
PMID: 38910589
Multiple myeloma is a plasma cell neoplasm, which may present as a solitary plasmacytoma and, uncommonly, as an extramedullary plasmacytoma. Intracranial plasmacytomas may manifest in central nervous system involvement as...
2.
Maxwell C, Joshi N, Feller C, McAree M, Hedayat H
Surg Neurol Int
. 2021 Sep;
12:371.
PMID: 34513138
Background: Arachnoid cysts (ACs) are cerebrospinal fluid-containing cysts located between the surface of the brain or spinal cord and arachnoid layer of the leptomeninges. ACs have been known to cause...
3.
Joshi N, Onaivi E
Adv Exp Med Biol
. 2020 Dec;
1264:131-153.
PMID: 33332008
With the increasing global use of medical and adult recreational use of cannabis and cannabinoids, this chapter provides overview of evidence from animal and human studies on psychiatric disorders and...
4.
Joshi N, Chandler D
Handb Clin Neurol
. 2020 Oct;
175:167-176.
PMID: 33008523
The central noradrenergic system comprises multiple brainstem nuclei whose cells synthesize and release the catecholamine transmitter norepinephrine (NE). The largest of these nuclei is the pontine locus coeruleus (LC), which...
5.
Joshi N, McAree M, Chandler D
Vitam Horm
. 2020 Jul;
114:53-69.
PMID: 32723550
The mammalian brain contains many regions which synthesize and release the hormone and transmitter corticotropin releasing factor. This peptide is a key player in the function of the hypothalamic-pituitary-adrenal axis...
6.
Choi S, Ma T, Ding Y, Cheung T, Joshi N, Sulzer D, et al.
Elife
. 2020 Jul;
9.
PMID: 32687053
Changes in striatal cholinergic interneuron (ChI) activity are thought to contribute to Parkinson's disease pathophysiology and dyskinesia from chronic L-3,4-dihydroxyphenylalanine (L-DOPA) treatment, but the physiological basis of these changes is...
7.
Melachroinou K, Kang M, Liong C, Narayan S, Levers N, Joshi N, et al.
Mov Disord
. 2020 Jul;
35(11):2095-2100.
PMID: 32652692
Background: Leucine-rich repeat kinase 2 kinase inhibitors are being vigorously pursued as potential therapeutic options; however, there is a critical need for sensitive and quantitative assays of leucine-rich repeat kinase...
8.
Padmanabhan S, Lanz T, Gorman D, Wolfe M, Joyce A, Cabrera C, et al.
J Parkinsons Dis
. 2020 Feb;
10(2):623-629.
PMID: 32007961
The phosphorylated form of LRRK2, pS935 LRRK2, has been proposed as a target modulation biomarker for LRRK2 inhibitors. The primary aim of the study was to characterize and qualify this...
9.
Joshi N, Onaivi E
Adv Exp Med Biol
. 2019 Jul;
1162:1-12.
PMID: 31332731
Marijuana/cannabinoid research has been transformed into mainstream science during the last half-century. Evidence based research and remarkable biotechnological advances demonstrate that phytocannabinoids and endocannabinoid (eCBs) acting on cannabinoid receptors (CBRs)...
10.
Borodovitsyna O, Joshi N, Chandler D
Neural Plast
. 2018 Jul;
2018:1892570.
PMID: 30008741
Neural plasticity plays a critical role in mediating short- and long-term brain responses to environmental stimuli. A major effector of plasticity throughout many regions of the brain is stress. Activation...